Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 for Calf Strain Research: Study Comparison

Rat gastrocnemius transection (2014) 10 mcg/kg IP daily × 14 days Muscle healing score improved 67% vs control Complete regeneration at 28 days vs persistent fibrosis in controls Histology showed organised myofibril structure, minimal scar tissue Most cited pr

This comparison does not assign a generated winner or score.

  • Rat gastrocnemius transection (2014)
  • 10 mcg/kg IP daily × 14 days
  • Muscle healing score improved 67% vs control
  • Complete regeneration at 28 days vs persistent fibrosis in controls
  • Histology showed organised myofibril structure, minimal scar tissue
  • Most cited protocol. Established baseline for dosing and timeline expectations
  • Rat Achilles tendon rupture (2016)
  • 10 mcg/kg SC daily × 21 days
  • Tensile strength 78% of pre-injury at day 21
  • Functional weight-bearing restored at day 10 vs day 18 in controls
  • Collagen fibre alignment score 35% higher than control group
  • Demonstrated mechanism applies across tendon and muscle tissue types
  • Rat gastrocnemius crush injury (2018)
  • 500 mcg/kg IM every 48 hours × 14 days
  • 82% tensile strength recovery vs 54% control
  • Inflammation resolution 40% faster than untreated
  • FAK-paxillin pathway activation confirmed via immunohistochemistry
  • Higher intermittent dosing produced comparable outcomes to daily low-dose. Suggests threshold effect
  • Rabbit quadriceps strain (2020)
  • 250 mcg/kg SC daily × 10 days
  • VEGF expression 3.2× baseline at injury site
  • Return to normal gait mechanics at day 12 vs day 19
  • Capillary density increased 58% vs control tissue
  • Larger animal model validates mechanism seen in rodents. Dose scaling remains unclear
More references

Related material